Secondary prevention in patients with vascular disease. A population based study on the underuse of recommended medications

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 84, Issue 3, 2013, Pages 348-353

  Béjot, Yannick ^a   Zeller, Marianne ^b   Lorgis, Luc ^b   Troisgros, Odile ^a   Aboa Eboulé, Corine ^a,b   Osseby, Guy Victor ^a   Giroud, Maurice ^a   Cottin, Yves ^a  

^a DIJON UNIVERSITY HOSPITAL   (France)

^b LPPCE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; DRUG USE; HUMAN; OBSERVATIONAL STUDY; PATIENT ATTITUDE; POPULATION RESEARCH; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECURRENT DISEASE; SECONDARY PREVENTION; VASCULAR DISEASE;

EID: 84874086027     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp-2012-303267     Document Type: Article

References (28)

1. Yusuf S, Reddy S, Ounpuu S, et al. Global burden of cardiovascular disease. Part II: variations in cardiovascular disease by specific ethnic groups and geographic regions and prevention strategies. Circulation 2001;104:2855-64.
2. Bhatt DL, Steg PG, Ohman EM, et al. International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis. JAMA 2006;295:180-9.
3. Furie KL, Kasner SE, Adams RJ, et al. Guidelines for the prevention of stroke in patients with stroke or transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2011;42:227-76.
4. Wright RS, Anderson JL, Adams CD, et al. 2011 ACCF/AHA focused update of the guidelines for the management of patients with unstable angina/non-T- elevation myocardial infarction (updating the 2007 guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation 2011;123:2022-60.
5. Kushner FG, Hand M, Smith SC Jr, et al. 2009 focused updates: ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction (updating the 2004 guideline and 2007 focused update) and ACC/AHA/SCAI guidelines on percutaneous coronary intervention (updating the 2005 guideline and 2007 focused update): a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation 2009;120:2271-306.
6. Hirsch AT, Haskal ZJ, Hertzer NR, et al. ACC/AHA guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Associations for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on practice guidelines (writing committee to develop guidelines for the management of patients with peripheral arterial disease) - summary of recommendations. J Vasc Interv Radiol 2006;17:1383-97.
7. Mehta RH, Roe MT, Chen AY, et al. Recent trends in the care of patients with non-ST-segment elevation acute coronary syndromes: insights from the CRUSADE initiative. Arch Intern Med 2006;166:2027-34.
8. Husted S. Evidence-based prescribing and adherence to antiplatelet therapy - how much difference do they make to patients with atherothrombosis? Int J Cardiol 2009;134:150-9.
9. Saposnik G, Goodman SG, Leiter LA, et al. Applying the evidence: do patients with stroke, coronary artery disease, or both achieve similar treatment goals? Stroke 2009;40:1417-24.
10. Asberg S, Henriksson KM, Farahmand B, et al. Ischemic stroke and secondary prevention in clinical practice: a cohort study of 14,529 patients in the Swedish Stroke Register. Stroke 2010;41:1338-42.
11. Wei JW, Wang JG, Huang Y, et al. Secondary prevention of ischemic stroke in urban China. Stroke 2010;41:967-74.
12. Flu HC, Tamsma JT, Lindeman JH, et al. A systematic review of implementation of established recommended secondary prevention measures in patients with PAOD. Eur J Vasc Endovasc Surg 2010;39:70-86.
13. Glader EL, Sjölander M, Eriksson M, et al. Persistent use of secondary preventive drugs declines rapidly during the first 2 years after stroke. Stroke 2010;41:397-401.
14. Bushnell CD, Olson DM, Zhao X, et al. Secondary preventive medication persistence and adherence 1 year after stroke. Neurology 2011;77:1182-90.
15. De Schryver EL, van Gijn J, Kappelle LJ, et al. Non-adherence to aspirin or oral anticoagulants in secondary prevention after ischaemic stroke. J Neurol 2005;252:1316-21.
16. Wang Y, Wu D, Wang Y, et al. A survey on adherence to secondary ischemic stroke prevention. Neurol Res 2006;28:16-20.
17. Newby LK, LaPointe NM, Chen AY, et al. Long-term adherence to evidence-based secondary prevention therapies in coronary artery disease. Circulation 2006;113:203-12.
18. Girot M, Mackowiak-Cordoliani MA, Deplanque D, et al. Secondary prevention after ischemic stroke. Evolution over time in practice. J Neurol 2005;252:14-20.
19. Kotseva K, Wood D, De Backer G, et al. EUROASPIRE III: a survey on the lifestyle, risk factors and use of cardioprotective drug therapies in coronary patients from 22 European countries. Eur J Cardiovasc Prev Rehabil 2009;16:121-37.
20. Cacoub PP, Zeymer U, Limbourg T, et al. Effects of adherence to guidelines for the control of major cardiovascular risk factors on outcomes in the Reduction of Atherothrombosis for Continued Health (REACH) Registry Europe. Heart 2011;97:660-7.
21. Mechtouff L, Touzé E, Steg PG, et al. Worse blood pressure control in patients with cerebrovascular or peripheral arterial disease compared with coronary artery disease. J Intern Med 2010;267:621-33.
22. Gentil A, Béjot Y, Lorgis L, et al. Comparative epidemiology of stroke and acute myocardial infarction: the Dijon Vascular project (Diva). J Neurol Neurosurg Psychiatry 2009;80:1006-11.
23. Henrotin JB, Zeller M, Lorgis L, et al. Evidence of the role of short-term exposure to ozone on ischaemic cerebral and cardiac events: the Dijon Vascular Project (DIVA). Heart 2010;96:1990-6.
24. Béjot Y, Aboa-Eboulé C, Durier J, et al. Prevalence of early dementia after first-ever stroke: a 24-year population-based study. Stroke 2011;42:607-12.
25. WHO. The World Health Report 2000: Health Systems Improving Performance. Geneva: WHO, 2000.
26. Zeller M, Steg PG, Ravisy J, et al. Relation between body mass index, waist circumference, and death after acute myocardial infarction. Circulation 2008;118:482-90.
27. Amarenco P, Bogousslavsky J, Callahan A III, et al. High-dose atorvastatin after stroke or transient ischemic attack. N Engl J Med 2006;355:549-59.
28. Pendlebury ST, Rothwell PM. Prevalence, incidence, and factors associated with pre-stroke and post-stroke dementia: a systematic review and meta-analysis. Lancet Neurolology 2009;8:1006-18.